Pure Global

“AtriCure” AtriClip Gillinov-Cosgrove LAA Exclusion System - Taiwan Registration 7d3cfbe36f2bad13c0ada5bf2ad70fbc

Access comprehensive regulatory information for “AtriCure” AtriClip Gillinov-Cosgrove LAA Exclusion System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7d3cfbe36f2bad13c0ada5bf2ad70fbc and manufactured by Atricure, Inc.. The authorized representative in Taiwan is ASIA HEALTH CARE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
7d3cfbe36f2bad13c0ada5bf2ad70fbc
Registration Details
Taiwan FDA Registration: 7d3cfbe36f2bad13c0ada5bf2ad70fbc
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“AtriCure” AtriClip Gillinov-Cosgrove LAA Exclusion System
TW: “艾翠科” 左心耳閉塞夾系統
Risk Class 2
MD

Registration Details

7d3cfbe36f2bad13c0ada5bf2ad70fbc

Ministry of Health Medical Device Import No. 034494

DHA05603449403

Company Information

United States

Product Details

For details, it is Chinese approved copy of the imitation order

E Cardiovascular devices

E9999 Other

Imported from abroad

Dates and Status

Apr 09, 2021

Apr 09, 2026